Update on Regulatory Submission for Aducanumab in the European Union
Biogen to seek re-examination following CHMP negative opinion for aducanumabCAMBRIDGE, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq:...
Year: 2021
The Ensign Group, Inc. Increases Quarterly Dividend to $0.055 Per Share
SAN JUAN CAPISTRANO, Calif., Dec. 17, 2021 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (NASDAQ: ENSG), the parent company of...
LIDDS patent covering the NanoZolid® production process granted in China
UPPSALA, SWEDEN – LIDDS AB (publ) announces today that its most recent patent family on the NanoZolid® production process, and...
Aino Health AB (publ): Transcom expands Aino HealthManager to the Netherlands
Tanscom chooses to expand HealthManager as a SaaS solution to support managers and increase productivity and well-being among their employees.Transcom...
EssilorLuxottica : EssilorLuxottica and GrandVision enter into an agreement with Vision Group for the sale of stores in Italy
EssilorLuxottica and GrandVision enter into an agreementwith Vision Group for the sale of stores in Italy Charenton-le-Pont, France, Schiphol, The...
On heels of global strategic partnership announced today, GENFIT acquires rights to novel asset
Exclusive rights for a novel early-stage asset acquired from Genoscience Pharma in cholangiocarcinoma in the United States, Canada and EuropePhase...
Basilea announces FDA approval of Investigational New Drug application for novel oncology drug candidate BAL0891
Phase 1 study in patients with advanced solid tumors planned to start in the first quarter of 2022Ad hoc announcement...
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis, as part of a long-term global partnership
GENFIT: Ipsen and GENFIT enter into exclusive licensing agreement for elafibranor, a Phase III asset evaluated in Primary Biliary Cholangitis,...
Hyloris Enters into Strategic Partnership with Vaneltix for Treatment of Acute Pain in Interstitial Cystitis
Access to AlenuraTM, a dual mode-of-action advanced clinical candidate for the treatment of acute pain in interstitial cystitis/bladder pain syndrome...
ObsEva Announces Positive CHMP Opinion for Linzagolix, an Oral GnRH Antagonist, for the Treatment of Uterine Fibroids
-European Commission Decision Anticipated in Q1 2022- -CHMP recommendation follows the recent acceptance of the linzagolix uterine fibroids NDA by...
Addex Raises $10.0 Million in Equity Financing
Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 17, 2021 – Addex Therapeutics Ltd (SIX: ADXN and...
Sequana Medical to Attend 11th Annual LifeSci Partners Corporate Access Event and H.C. Wainwright BIOCONNECT Virtual Conference
CEO Ian Crosbie to participate in a panel discussion on “MedTech and digital tools: What is the Mindset for 2022?”GHENT, Belgium,...
Extendicare Announces December 2021 Dividend of C$0.04 per Share
MARKHAM, Ontario, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced that it has...
Bioasis Announces Annual General Meeting Results
NEW HAVEN, Conn., Dec. 16, 2021 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (TSXV:BTI; OTCQB:BIOAF), (the “Company” or “Bioasis”), a biopharmaceutical...
Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warrant Overhang
DAVIS, Calif., Dec. 16, 2021 (GLOBE NEWSWIRE) -- During November and December 2021, certain warrant holders in Marrone Bio Innovations, Inc....
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., Dec. 16, 2021 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (Nasdaq: XRAY), announced that its Board of...
Leveljump Healthcare Corp. Acquires Additional 2.3% of Real Time Medical; Exercises Right to Acquire Additional 1.5% of Shaw Lens and Shaw Vision; Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 17, 2021) - Leveljump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("Leveljump" or the...
TeleRay and Radiobotics Join Forces to Provide Radiology AI on Fastest Growing Radiology Telehealth Platform
AUSTIN, Texas, Dec. 17, 2021 /PRNewswire/ -- In the United States, 23% of all adults—over 54 million people—have arthritis and x-rays...
Sensor Clarifies Its Proposed Change of Business
Toronto, Ontario--(Newsfile Corp. - December 16, 2021) - Further to its press release of December 7, 2021, Sensor Technologies Corp....
The Hub Craft Announces Partnership with Major Bloom
The Hub Craft is proud to announce manufacturing and retail partnerships with Worcester based, Major BloomFitchburg, Massachusetts--(Newsfile Corp. - December...